Press releases

Month Year

Email alerts

Nov 13, 2012

FDA Approves Medtronic Stent Graft for Aortic Transection Repair

New Indication Expands Labeled Uses for Valiant® Captivia® System in U.S.; Six-Month Results of RESCUE Trial Will Be Presented at VEITHsymposium

MINNEAPOLIS -- Nov. 13, 2012 -- Consistent with its commitment to clinical excellence, Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the...
Nov 13, 2012

Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2013

MINNEAPOLIS - Nov. 13, 2012 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2013 on Tuesday, November 20, 2012. A news...
Nov 13, 2012

Medtronic Issues Statement on Court of Appeals Ruling

MINNEAPOLIS - November 13, 2012 - The Federal Circuit Court of Appeals has affirmed the April 2010 jury verdict from the Federal District Court of Delaware that the CoreValve® System infringed a...
Nov 6, 2012

Significantly Better Patient Outcomes Gained from Pacing Both Ventricles in Patients with AV Block and Reduced Pumping Function

Medtronic Biventricular Pacing Reduces Risk of Death and Heart Failure Visits by 27 Percent, Demonstrating Superiority and Real-World Clinical Benefits Compared to Right Ventricular Pacing

MINNEAPOLIS and LOS ANGELES - Nov. 6, 2012 - Medtronic, Inc. (NYSE: MDT) today announced interim findings from the BLOCK HF trial, which show that biventricular (BiV) pacing may offer a...
Nov 5, 2012

Medtronic Foundation Donates $250,000 to Hurricane Sandy Relief Efforts

MINNEAPOLIS - Nov. 5 - 2012 - Medtronic, Inc. (NYSE: MDT) announced today a grant of $250,000 from the Medtronic Foundation to the American Red Cross to support relief efforts in areas affected by...

Show per page